Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
0.712
+0.035 (5.12%)
At close: Jan 21, 2025, 4:00 PM
0.683
-0.029 (-4.14%)
After-hours: Jan 21, 2025, 7:29 PM EST
Verrica Pharmaceuticals Stock Forecast
VRCA's stock price has decreased by -87.95% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for VRCA stock have an average target of 6.00, with a low estimate of 2.00 and a high estimate of 10. The average target predicts an increase of 742.70% from the current stock price of 0.71.
Analyst Consensus: Hold
* Price targets were last updated on Nov 5, 2024.
Analyst Ratings
The average analyst rating for VRCA stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 1 | 1 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 2 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 6 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 6, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 5, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $11 → $2 | Buy → Hold | Downgrades | $11 → $2 | +180.90% | Nov 5, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +1,304.49% | Oct 21, 2024 |
Financial Forecast
Revenue This Year
8.42M
from 5.12M
Increased by 64.32%
Revenue Next Year
14.63M
from 8.42M
Increased by 73.76%
EPS This Year
-1.63
from -1.48
EPS Next Year
-0.60
from -1.63
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 10.8M | 26.3M | 63.0M | |||
| Avg | 8.4M | 14.6M | 33.3M | |||
| Low | 7.1M | 4.9M | 14.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 111.0% | 211.8% | 330.6% | |||
| Avg | 64.3% | 73.8% | 127.3% | |||
| Low | 37.7% | -42.0% | -0.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.55 | -0.32 | -0.03 | |||
| Avg | -1.63 | -0.60 | -0.38 | |||
| Low | -1.68 | -0.93 | -0.88 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.